The course of a patient with an olfactory neuroblastoma treated with conventional doses of chemotherapeutic agents and radiotherapy is presented. The patient survived 34 months after tumour necrosis with resultant pneumocephalus requiring surgical intervention. RESUME: Pneumo-encephale suite ay traitement d'un esthesioneuroblastome. Nous rapportons 1'evolution d'un patient presentant un neuroblastome olfactif traite par des doses conventionnelles de chimiotherapie et de radiotherapie. Le patient a survecu 34 mois apres la necrose de la tumeur qui a occasionne un pneumo-encephale necessitant un traitement chirurgical.
Esthesioneuroblastoma, or olfactory neuroblastoma, is a malignant neuroblastic tumour thought to arise from the olfactory epithelium of the nasal cavity. 1 2 The tumour is sufficiently rare that many reports in the literature are either small series [3] [4] [5] [6] or isolated cases with reviews of the literature. [7] [8] [9] This case report adds to this body of information by summarizing the course of an infrequently diagnosed illness and illustrating a previously unrecognized complication after treatment.
CASE REPORT
A 64-year-old man presented in May 1987 complaining of progressive left eye pain and periorbital swelling over a six month period. Further questioning revealed a 4 year history of anosmia with frequent episodes of epistaxis from the left nares. The previous medical history was unremarkable. The patient was a retired aircraft maintenance man and smoked approximately '/2 pack per day for 22 years.
Physical examination revealed restricted movement of the left eye causing mild diplopia in all directions. Evident proptosis of the left eye with chemosis was noted and a 1 cm mass in the left medial canthus was palpable. No cervical lymphadenopathy was palpable. The chest xray was unremarkable. A computed tomographic (CT) scan of the head demonstrated an extensive mass involving the cribriform plate with bone destruction, abutting the orbit and invading both frontal lobes of the brain. A magnetic resonance image (MRI) scan (Signa, General Electric Medical Systems, Milwaukee, Wisconsin) was obtained to further delineate the mass (see Figure I ). The tumour bridged the cribriform plate and involved the brain and sinuses (Kadish stage C'°). Adriamcycin 90 nmg (50 mg/m2) IV and Vincristine 2 mg IV. This regimen was repeated two weeks later and a follow up MRI scan showed no alteration of tumour morphology. The patient then received radiotherapy consisting of 5,000 centiGray (tumour dose) in 25 fractions over 6 weeks with shielding of the eyes and uninvolved brain.
In October 1987, within two weeks of the last radiotherapy, the patient presented with subacute progressive confusion. An MRI scan was obtained (Figures 2 and 3 ) revealing extensive tissue destruction and pneumocephaly. A fistulous tract extending from the nasopharynx through necrotic tissue into the right frontal lobe was found at surgery. 
LE JOURNAL CANADIEN DES SCIENCES NEUROLOGIQUES
Histologic examination of the resected tumour (see Figure 4 ) revealed a highly cellular mass composed of small cells with dense nuclei superimposed on a fine fibrillar matrix. The cells possess little cytoplasm and showed minimal pleomorphism. No mitoses were seen and definite rosette formation was not appreciated. The nests and cords of tumour cells were separated by irregular septae of fibrous tissue. Extensive areas of necrosis were seen. Immunohistochemical stains for glial fibrillary acidic protein (GFAP), cytokeratin (CK), human common leukocyte antigen (HLA) and neurofilament (NF) were negative. Neuron specific enolase (NSE) was positive and occasional cells showed positivity for S-100 protein." Ultrastructural analysis of the tumour was not obtained. The pathologic diagnosis was olfactory neuroblastoma.
The patient was discharged for convalescence into the care of his family physician. His postoperative mental state showed marked memory impairment and personality change. Over the ensuing 34 months progressive bilateral cervical lymphadenopathy reached "grapefruit size" and the patient succumbed with respiratory complications of upper airway obstruction in August of 1990. No further investigations or autopsy had been performed.
DISCUSSION
Olfactory neuroblastoma is a neuroepithelial-cell-derived neoplasm of the olfactory mucosa composed of homogeneous small round cells which contain neurosecretory granules. The histologic homogeneity contrasts with case reports which demonstrate speckled calcification throughout on CT examination, 1213 ganglioneuroblastic transformation following subtotal resection and radiotherapy, 14 and dual differentiation of the tumour into melanoma and esthesioneuroblastoma after transplantation into mice. 15 The natural history and optimal treatment of olfactory neuroblastoma is not well defined. 16 A review of reported cases by Elkon et al. suggests that the three year survival correlates with staging and varies from 52.9 -88.9% when surgical and radiation therapy are administered. 3 Combined treatment with local resection and radiation in disease spread to the adjacent paranasal sinuses (Kadish stage B) resulted in local tumour recurrence in 2 out of 7 patients. 17 Patients with tumour presenting extending beyond the nasal cavity and sinuses presently receive radiation therapy of 6,000-6,500 centiGray in 7 weeks.
Chemotherapy has been suggested as palliative therapy and may have a beneficial effect on olfactory neuroblastoma in approximately 62% of patients when combined with other treat- ment modalities. 18 Combination chemotherapy with cyclophosphamide (150 mg/m2 daily for 7 days), doxorubicin (35 mg/m 2 ) and vincristine (1 mg/m 2 ) has previously been administered with radiation therapy. 19 Four of five patients with Kadish stage C olfactory neuroblastoma either died (3) or still had residual tumour (1) after treatment with supralethal high dose chemotherapy followed by cryopreserved autologous bone marrow transplantation. 20 The remaining patient was alive with no tumour evident eighteen months after transplantation. Spontaneous pneumocephaly has been described following treatment of nasopharyngeal carcinoma, 21 nasal polypectomy 22 and radiation therapy of pituitary adenoma. 23 Pneumocephalus Figure may result from cranial trauma, gas forming infection of the paranasal sinuses or intracranial cavity or consequent to surgical opening of the dura. Spontaneous pneumocephalus in the absence of predisposing factors is usually thought to occur through congenital bony and dural defects of the skull. 24 The intracranial air can be localized to any of the extradural, subdural, subarachnoid intraparenchymal or intraventricular spaces. In the present case a fistulous tract through necrotic tissue allowed communication of the ventricular system with the nasal cavity.
